New SEC Form D filing
Frontier Bio Corp, 2026-11-10
A new SEC Form D private-offering notice from Hayward, CA, a $1,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Develops lab grown vascular grafts and tissue using 3D bioprinting to replace animal tissue testing and reduce organ transplant waitlists.
Filed 2026-11-10Filed to raise $1,000,000First money in 2026-10-27Raised so far $380,000HQ (as filed) Hayward, CASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified frontierbio.com↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- TOWN COURT COLLECTIVE LLC, 2026-11-10, $300K, Oakland, CA
- Orcosa Inc., 2026-11-12, $11.5M, Ewing, NJ
- Kestrel Defense Systems Inc., 2026-11-10, $120K, Ventura, CA
- SUTOL BIO, Inc., 2026-11-10, $474K, Cambridge, MA
- Kulea Inc., 2026-11-10, $750K, San Francisco, CA
- Chickadee Biomedicines, Inc., 2026-11-10, $1M, New York, NY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.